The committee for SCREEN will receive and answer all new queries for collaboration and review them for the following criteria:
- That the research is relevant to the strategy at SDCC with an emphasis on world-class patient-centered diabetes care.
- That the available resources and patient population match the research objectives and enrollment criteria.
- That there is synergy between clinical research at SDCC.
It is no longer possible to initiate external collaborations with individual researchers outside of SCREEN. All clinical trials initiated and conducted at SDCC need to go through the SCREEN process.
If your participants need to sign an informed consent, then it’s likely that your project needs to be approved by SCREEN. If in doubt, contact Michelle Ellefson, Head of Research & Innovation at SDCC.
Already affiliated or interested in a life science collaboration?
Follow the SDCC Investigators’ path if you are already affiliated or have a joint appointment with SDCC,
If you are interested in initiating a life science collaboration with SDCC, please follow the path for External Collaborators.
GATE refers to the name of the forms that must be filled out.
Applicants will be notified within 7 business days of the SCREEN SC decision.
SCREEN Steering Committee Members
Birgitte Brock, head of Research, chairman
Peter Rossing, head of Complications Research
Tina Vilsbøll, head of Clinic
Filip Krag Knop, head of Clinical Metabolic Physiology Research
Ingrid Willaing, head of Clinical Management Research
Evy Connie Ottesen, head of Core Lab
Michelle Ellefson, head of Research and Innovation
SCREEN 2019 Deadlines & SC Meetings: To Be Determined .
A more detailed description of SCREEN can be found in the white paper.